ArticleFrontiers in immunology2022

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.

Jack T Whelan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.